Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 2COHANCE LIFESCIENCES LIMITED Mumbai IN
02 1SCI PHARMTECH, INC. Taoyuan City TW
03 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
04 2HETERO LABS LIMITED Hyderabad IN
05 1MACLEODS PHARMACEUTICALS LIMITED Mumbai IN
06 1MSN ORGANICS PRIVATE LIMITED Bibinagar Village IN
07 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
08 1ZYDUS LIFESCIENCES LIMITED Vadodara IN
01 8Atomoxetine hydrochloride
02 1Atomoxetine hydrochloride, Process 2
03 1Atomoxetine hydrochloride, Process-II
01 9India
02 1Taiwan
01 10Valid
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2015-150 - Rev 01
Status : Valid
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 2640
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Certificate Number : CEP 2017-029 - Rev 04
Status : Valid
Issue Date : 2024-12-12
Type : Chemical
Substance Number : 2640
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Atomoxetine Hydrochloride, Process 2
Certificate Number : CEP 2019-212 - Rev 02
Status : Valid
Issue Date : 2024-07-10
Type : Chemical
Substance Number : 2640
Certificate Number : CEP 2014-241 - Rev 01
Status : Valid
Issue Date : 2024-01-17
Type : Chemical
Substance Number : 2640
Certificate Number : R1-CEP 2015-128 - Rev 01
Status : Valid
Issue Date : 2022-08-29
Type : Chemical
Substance Number : 2640
Atomoxetine Hydrochloride, Process-II
Certificate Number : R0-CEP 2020-091 - Rev 01
Status : Valid
Issue Date : 2021-03-19
Type : Chemical
Substance Number : 2640
Certificate Number : CEP 2017-073 - Rev 02
Status : Valid
Issue Date : 2024-04-11
Type : Chemical
Substance Number : 2640
Certificate Number : R1-CEP 2016-025 - Rev 00
Status : Valid
Issue Date : 2022-09-15
Type : Chemical
Substance Number : 2640
Certificate Number : CEP 2013-271 - Rev 02
Status : Valid
Issue Date : 2024-07-22
Type : Chemical
Substance Number : 2640
Certificate Number : R0-CEP 2019-236 - Rev 01
Status : Valid
Issue Date : 2022-07-11
Type : Chemical
Substance Number : 2640
A Atomoxetine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atomoxetine Hydrochloride, including repackagers and relabelers. The FDA regulates Atomoxetine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atomoxetine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atomoxetine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atomoxetine Hydrochloride supplier is an individual or a company that provides Atomoxetine Hydrochloride active pharmaceutical ingredient (API) or Atomoxetine Hydrochloride finished formulations upon request. The Atomoxetine Hydrochloride suppliers may include Atomoxetine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Atomoxetine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Atomoxetine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Atomoxetine Hydrochloride Certificate of Suitability (COS). The purpose of a Atomoxetine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atomoxetine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atomoxetine Hydrochloride to their clients by showing that a Atomoxetine Hydrochloride CEP has been issued for it. The manufacturer submits a Atomoxetine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atomoxetine Hydrochloride CEP holder for the record. Additionally, the data presented in the Atomoxetine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atomoxetine Hydrochloride DMF.
A Atomoxetine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atomoxetine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atomoxetine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
We have 8 companies offering Atomoxetine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?